Death rate and pulmonary function in patients with chronic non-specific lung diseases (CNSLD) after a 10-year follow-up.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001249:Asthma / Q000401:mortality; D001945:Breathing Exercises; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006935:Hypercapnia; D000860:Hypoxia; D008171:Lung Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality* / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010044:Outpatient Clinics, Hospital; D011379:Prognosis; D012129:Respiratory Function Tests; D014692:Ventilation-Perfusion Ratio
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents